Journal of the Neurological SciencesVolume 429, Supplement, October 2021, 117795Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumabAuthor links open overlay panelAntonio Gallo a, Rocco Capuano a, Giovanna Donnarumma b, Alvino Bisecco a, Elena Grimaldi b, Miriana Conte a, Alessandro D'Ambrosio a, Massimiliano Galdiero b, Gioacchino Tedeschi aShow moreShareCitehttps://doi.org/10.1016/j.jns.2021.117795Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract